Pretty lady training in a summer park. Brunette doing yoga. Girl in a sportsuit.

What Does FDA Think of AI?

Start
Speaking at CES 2024 earlier this year, U.S. Food and Drug Administration (FDA) Commissioner Robert Califf expressed significant concerns about the FDA’s ability to effectively regulate artificial intelligence (AI) in the healthcare sector. While acknowledging that AI presents significant opportunities in terms of both improving patient outcomes and giving doctors and nurses more time to devote to patient care, he also stressed that effective regulation is going to be essential in the years to…
By: Gardner Law
Previous Story

Cyber Incident Reporting Obligations for Public Companies under the SEC’s New Cybersecurity Rules

Next Story

EnforceMintz — A 2023 Legislative Push to Address AI in Health Care Will Continue in 2024